Company / Total Debt
TherapeuticsMD, Inc. Total Debt History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$188.3M
FY2021
5-year range
$188.3M / $237.7M
FY2018-FY2021
Trend
-20.8%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $195M to $188M over the past 2 years.
Based on SEC 10-K filings.
$188M in FY2021 with a 3-year CAGR of +36.9%.
Improved from $195M to $188M over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- +36.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +36.9%, indicating consistent growth.
- In FY2021, total debt decreased 20.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $188.3M | -20.8% |
| FY2020 | $237.7M | +22.1% |
| FY2019 | $194.6M | +165.2% |
| FY2018 | $73.4M | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026